57 results
8-K
EX-1.1
EVOK
Evoke Pharma Inc
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm
.
(e) General Disclosure Package. As of the Applicable Time, neither (i) the General Use Issuer Free Writing Prospectus(es) issued at or prior … to be included in the General Disclosure Package, all considered together (collectively, the “General Disclosure Package”), nor (ii) any individual Limited
8-K
EX-1.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
Prospectus.
“Pricing Disclosure Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Pricing … Statement, the Pricing Disclosure Package or the Prospectus.
2.3 No Stop Orders, etc. Neither the Commission nor, to the Company’s knowledge, any state
8-K
EVOK
Evoke Pharma Inc
27 Jun 19
Other Events
8:32am
request and meeting package to the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) dated April 1, 2019 regarding … .
The type A meeting, if granted, is expected to occur within thirty days of FDA’s receipt of the meeting request and meeting package. Evoke will provide
DEFA14A
1my88 mv80jztp
15 Mar 22
Additional proxy soliciting materials
4:05pm
DEFA14A
76w0m g9pzs
8 Apr 14
Additional proxy soliciting materials
12:00am
DEFA14A
mxjp7f9 0j98
14 Apr 20
Additional proxy soliciting materials
8:35am
DEFA14A
a4m68u8y67kpmiz
10 Apr 24
Additional proxy soliciting materials
3:35pm
DEFA14A
hdodimr33e1crk8b
21 Mar 19
Additional proxy soliciting materials
8:31am
DEFA14A
2bgr55k 3w4wr
26 Mar 21
Additional proxy soliciting materials
8:31am
DEFA14A
26m ngwa10c
29 Mar 23
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
blt28vqd g8vz
8 Aug 19
Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
8:07am
8-K
xt18vnpq0b3k7 fdvk
8 Aug 19
Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
8:07am